CP1 0.00% 17.0¢ cannpal animal therapeutics limited

Ann: CannPal Enters into Exclusive Licencing Agreement with CSIRO, page-9

  1. 7,412 Posts.
    lightbulb Created with Sketch. 833
    Its animal pharma peers are at least 10x its current market cap. And now they have a globally exclusive CSIRO delivery mechanism to boot.

    New 52 week high, but still hardly any shares on issue, with the Top 20 owning about 70%.
 
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.